Literature DB >> 31642882

Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia.

Matthew L MacDonald1,2, Megan Garver1, Jason Newman1, Zhe Sun3, Joseph Kannarkat1, Ryan Salisbury1, Jill Glausier1, Ying Ding3, David A Lewis1, Nathan Yates2, Robert A Sweet1.   

Abstract

Importance: Findings from unbiased genetic studies have consistently implicated synaptic protein networks in schizophrenia, but the molecular pathologic features within these networks and their contribution to the synaptic and circuit deficits thought to underlie disease symptoms remain unknown. Objective: To determine whether protein levels are altered within synapses from the primary auditory cortex (A1) of individuals with schizophrenia and, if so, whether these differences are restricted to the synapse or occur throughout the gray matter. Design, Setting, and Participants: This paired case-control study included tissue samples from individuals with schizophrenia obtained from the Allegheny County Office of the Medical Examiner. An independent panel of health care professionals made consensus DSM-IV diagnoses. Each tissue sample from an individual with schizophrenia was matched by sex, age, and postmortem interval with 1 sample from an unaffected control individual. Targeted mass spectrometry was used to measure protein levels in A1 gray matter homogenate and synaptosome preparations. All experimenters were blinded to diagnosis. Mass spectrometry data were collected from September 26 through November 4, 2016, and analyzed from November 3, 2016, to July 15, 2019. Main Outcomes and Measures: Primary measures were homogenate and synaptosome protein levels and their coregulation network features. Hypotheses generated before data collection were (1) that levels of canonical postsynaptic proteins in A1 synaptosome preparations would differ between individuals with schizophrenia and controls and (2) that these differences would not be explained by changes in total A1 homogenate protein levels.
Results: Synaptosome and homogenate protein levels were investigated in 48 individuals with a schizophrenia diagnosis and 48 controls (mean age in both groups, 48 years [range, 17-83 years]); each group included 35 males (73%) and 13 females (27%). Robust alterations (statistical cutoff set at an adjusted Limma P < .05) were observed in synaptosome levels of canonical mitochondrial and postsynaptic proteins that were highly coregulated and not readily explained by postmortem interval, antipsychotic drug treatment, synaptosome yield, or underlying alterations in homogenate protein levels. Conclusions and Relevance: These findings suggest a robust and highly coordinated rearrangement of the synaptic proteome. In line with unbiased genetic findings, alterations in synaptic levels of postsynaptic proteins were identified, providing a road map to identify the specific cells and circuits that are impaired in individuals with schizophrenia A1.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31642882      PMCID: PMC6813579          DOI: 10.1001/jamapsychiatry.2019.2974

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  67 in total

1.  Synaptic protein degradation underlies destabilization of retrieved fear memory.

Authors:  Sue-Hyun Lee; Jun-Hyeok Choi; Nuribalhae Lee; Hye-Ryeon Lee; Jae-Ick Kim; Nam-Kyung Yu; Sun-Lim Choi; Seung-Hee Lee; Hyoung Kim; Bong-Kiun Kaang
Journal:  Science       Date:  2008-02-07       Impact factor: 47.728

Review 2.  Spine Dynamics: Are They All the Same?

Authors:  Kalen P Berry; Elly Nedivi
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

3.  Details of attention and learning change in first-episode schizophrenia.

Authors:  Christine Mohn; Anne-Kari Torgalsbøen
Journal:  Psychiatry Res       Date:  2017-12-05       Impact factor: 3.222

4.  Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder.

Authors:  Michael J Gandal; Pan Zhang; Evi Hadjimichael; Rebecca L Walker; Chao Chen; Shuang Liu; Hyejung Won; Harm van Bakel; Merina Varghese; Yongjun Wang; Annie W Shieh; Jillian Haney; Sepideh Parhami; Judson Belmont; Minsoo Kim; Patricia Moran Losada; Zenab Khan; Justyna Mleczko; Yan Xia; Rujia Dai; Daifeng Wang; Yucheng T Yang; Min Xu; Kenneth Fish; Patrick R Hof; Jonathan Warrell; Dominic Fitzgerald; Kevin White; Andrew E Jaffe; Mette A Peters; Mark Gerstein; Chunyu Liu; Lilia M Iakoucheva; Dalila Pinto; Daniel H Geschwind
Journal:  Science       Date:  2018-12-14       Impact factor: 47.728

5.  Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

Authors:  R C Roberts; K A Barksdale; J K Roche; A C Lahti
Journal:  Schizophr Res       Date:  2015-07-22       Impact factor: 4.939

6.  Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.

Authors:  S Kristian Hill; Sue R Beers; Julie A Kmiec; Matcheri S Keshavan; John A Sweeney
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

7.  Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia.

Authors:  L J Garey; W Y Ong; T S Patel; M Kanani; A Davis; A M Mortimer; T R Barnes; S R Hirsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

8.  Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.

Authors:  María D Rubio; Krista Wood; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-04-09       Impact factor: 7.853

9.  PAK1 protein expression in the auditory cortex of schizophrenia subjects.

Authors:  Anthony J Deo; Isaac M Goldszer; Siyu Li; James V DiBitetto; Ruth Henteleff; Allan Sampson; David A Lewis; Peter Penzes; Robert A Sweet
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

10.  WGCNA: an R package for weighted correlation network analysis.

Authors:  Peter Langfelder; Steve Horvath
Journal:  BMC Bioinformatics       Date:  2008-12-29       Impact factor: 3.169

View more
  11 in total

Review 1.  The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2019-12-17       Impact factor: 3.575

2.  Postmortem Brains: What Can Proteomics Tell us About the Sources of Schizophrenia?

Authors:  Guilherme Reis-de-Oliveira; Bradley J Smith; Daniel Martins-de-Souza
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Forebrain expression of serine racemase during postnatal development.

Authors:  Oluwarotimi O Folorunso; Theresa L Harvey; Stephanie E Brown; Cristina Cruz; Ellie Shahbo; Ismail Ajjawi; Darrick T Balu
Journal:  Neurochem Int       Date:  2021-02-13       Impact factor: 3.921

Review 4.  The synapse in traumatic brain injury.

Authors:  Aimun A B Jamjoom; Jonathan Rhodes; Peter J D Andrews; Seth G N Grant
Journal:  Brain       Date:  2021-02-12       Impact factor: 13.501

5.  Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat.

Authors:  Christien Bowman; Ulrike Richter; Christopher R Jones; Claus Agerskov; Kjartan Frisch Herrik
Journal:  Front Psychiatry       Date:  2022-01-27       Impact factor: 4.157

6.  MR-Spectroscopy of GABA and Glutamate/Glutamine Concentrations in Auditory Cortex in Clinical High-Risk for Psychosis Individuals.

Authors:  Tineke Grent-'t-Jong; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Stephen R Williams; Peter J Uhlhaas
Journal:  Front Psychiatry       Date:  2022-03-29       Impact factor: 4.157

7.  Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies.

Authors:  Rosalinda C Roberts
Journal:  Mitochondrion       Date:  2020-11-20       Impact factor: 4.160

8.  MAP2 is differentially phosphorylated in schizophrenia, altering its function.

Authors:  M J Grubisha; X Sun; M L MacDonald; M Garver; Z Sun; K A Paris; D S Patel; R A DeGiosio; D A Lewis; N A Yates; C Camacho; G E Homanics; Y Ding; R A Sweet
Journal:  Mol Psychiatry       Date:  2021-02-01       Impact factor: 15.992

9.  Multiple alterations in glutamatergic transmission and dopamine D2 receptor splicing in induced pluripotent stem cell-derived neurons from patients with familial schizophrenia.

Authors:  Kana Yamamoto; Toshihiko Kuriu; Kensuke Matsumura; Kazuki Nagayasu; Yoshinori Tsurusaki; Noriko Miyake; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Mikiya Fujiwara; Masayuki Baba; Kohei Kitagawa; Tomoya Takemoto; Nanaka Gotoda-Nishimura; Tomohiro Takada; Kaoru Seiriki; Atsuko Hayata-Takano; Atsushi Kasai; Yukio Ago; Satoshi Kida; Kazuhiro Takuma; Fumihito Ono; Naomichi Matsumoto; Ryota Hashimoto; Hitoshi Hashimoto; Takanobu Nakazawa
Journal:  Transl Psychiatry       Date:  2021-10-25       Impact factor: 6.222

Review 10.  Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research.

Authors:  Melanie J Grubisha; Robert A Sweet; Matthew L MacDonald
Journal:  Front Mol Neurosci       Date:  2021-07-16       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.